SKI Market

Indian Indices

Sensex

84,695.54 -345.91
( -0.41%)

Global Indices

Nasdaq

48,728.27 -23.90
(-0.05%)

Dow Jones

6,949.98 -3.07
(-0.04%)

Hang Seng

50,388.37 -362.02
(-0.71%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.83 0.26
(0.29%)

EUR-INR

105.77 0.25
(0.24%)

GBP-INR

121.29 0.43
(0.36%)

JPY-INR

0.58 0.00
(0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5600262

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

23.39

121573.61

EPS(TTM)

Face Value()

Div & Yield %

64.35

1.06

Back

NCL Research and Financial Services Ltd - Board Meeting Intimation for Approval Of Unaudited Financial Results For QE Sept 30 2025

Oct 13,2025

NCL Research & Financial Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve Unaudited Financial Results for QE Sept 30 2025

84,695.54 -345.91 ( -0.41%)

48,728.27 -23.90 (-0.05%)

6,949.98 -3.07 (-0.04%)

50,388.37 -362.02 (-0.71%)

9,870.68 -18.54 (-0.19%)

89.83 0.26 (0.29%)

105.77 0.25 (0.24%)

121.29 0.43 (0.36%)

0.58 0.00 (0.43%)